Literature DB >> 10677319

The relationship between the sibling recurrence-risk ratio and genotype relative risk.

B A Rybicki1, R C Elston.   

Abstract

The recurrence-risk ratio of disease in siblings, lambdaS, is a standard parameter used in genetic analysis to estimate the statistical power for detection of a disease locus. However, the relationship between the underlying risk conferred by a disease-susceptibility allele and lambdaS has not been well described. The former is generally quantified as a genotype relative risk, gamma, and measures the ratio of disease risks between those with and those without the susceptibility genotype(s). We demonstrate that lambdaS varies significantly more with respect to gamma and the disease-allele frequency for two-locus multiplicative models than for other two-locus and for single-locus models. For the single- and two-locus dominant-inheritance models that we studied, when a disease-susceptibility allele had a frequency >/=.2, lambdaS had an upper limit of <10. In general, lambdaS values >10 are possible only under recessive inheritance, dominant inheritance with relatively rare (<5%) disease-susceptibility alleles, or when two or more disease loci have alleles acting either epistatically or multiplicatively. We introduce the idea of a restricted sib recurrence-risk ratio (lambda*S) estimated by restriction of sibships to those ascertained through a proband who already has a putative high-risk allele. A lambda*S larger than the lambdaS value estimated from randomly selected probands can serve as an indirect way of testing whether the posited susceptibility allele increases disease risk. Our results demonstrate that a lambdaS of 2-3 may portend successful mapping for a variety of genetic models but that, for some two-locus models, a lambdaS as high as 10 does not guarantee underlying genes easily mapped by linkage.

Mesh:

Year:  2000        PMID: 10677319      PMCID: PMC1288112          DOI: 10.1086/302778

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  21 in total

1.  Two-locus models of disease.

Authors:  R J Neuman; J P Rice
Journal:  Genet Epidemiol       Date:  1992       Impact factor: 2.135

2.  Linkage strategies for genetically complex traits. I. Multilocus models.

Authors:  N Risch
Journal:  Am J Hum Genet       Date:  1990-02       Impact factor: 11.025

3.  Linkage strategies for genetically complex traits. III. The effect of marker polymorphism on analysis of affected relative pairs.

Authors:  N Risch
Journal:  Am J Hum Genet       Date:  1990-02       Impact factor: 11.025

4.  The future of genetic studies of complex human diseases.

Authors:  N Risch; K Merikangas
Journal:  Science       Date:  1996-09-13       Impact factor: 47.728

5.  Genetic analysis of complex diseases.

Authors:  W K Scott; M A Pericak-Vance; J L Haines
Journal:  Science       Date:  1997-02-28       Impact factor: 47.728

Review 6.  Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization.

Authors:  B A Rybicki; M Major; J Popovich; M J Maliarik; M C Iannuzzi
Journal:  Am J Epidemiol       Date:  1997-02-01       Impact factor: 4.897

7.  Asymptotic properties of affected-sib-pair linkage analysis.

Authors:  P Holmans
Journal:  Am J Hum Genet       Date:  1993-02       Impact factor: 11.025

8.  Influence of the HLA-DRB1 locus on susceptibility and severity in rheumatoid arthritis.

Authors:  F C Hall; D E Weeks; J P Camilleri; L A Williams; N Amos; C Darke; K Gibson; K Pile; B P Wordsworth; J D Jessop
Journal:  QJM       Date:  1996-11

9.  Epistatic modeling in rheumatoid arthritis: an application of the Risch theory.

Authors:  A S Rigby; L Voelm; A J Silman
Journal:  Genet Epidemiol       Date:  1993       Impact factor: 2.135

10.  Predicting recurrence risks under epistatic models.

Authors:  T H Beaty; N E Maestri; D A Meyers; E A Murphy
Journal:  Am J Med Genet       Date:  1987-11
View more
  16 in total

Review 1.  Genetic factors underlying gluten-sensitive enteropathy.

Authors:  A S Peña; C Wijmenga
Journal:  Curr Allergy Asthma Rep       Date:  2001-11       Impact factor: 4.806

2.  Multiplex relative risk and estimation of the number of loci underlying an inherited disease.

Authors:  Paul Schliekelman; Montgomery Slatkin
Journal:  Am J Hum Genet       Date:  2002-11-21       Impact factor: 11.025

3.  Linkage at 12q24 with systemic lupus erythematosus (SLE) is established and confirmed in Hispanic and European American families.

Authors:  Swapan K Nath; Ana I Quintero-Del-Rio; Jeff Kilpatrick; Lourdes Feo; Maria Ballesteros; John B Harley
Journal:  Am J Hum Genet       Date:  2003-12-04       Impact factor: 11.025

Review 4.  Successful ageing: from cell to self.

Authors:  S J Lupien; N Wan
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-09-29       Impact factor: 6.237

5.  Genotype-specific recurrence risks as indicators of the genetic architecture of complex diseases.

Authors:  Montgomery Slatkin
Journal:  Am J Hum Genet       Date:  2008-07       Impact factor: 11.025

6.  Pathway-induced allelic spectra of diseases in the presence of strong genetic effects.

Authors:  George Kanoungi; Michael Nothnagel
Journal:  Hum Genet       Date:  2018-02-08       Impact factor: 4.132

7.  Familial aggregation in lone atrial fibrillation.

Authors:  Patrick T Ellinor; Danita M Yoerger; Jeremy N Ruskin; Calum A MacRae
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

8.  Hemophilic siblings with chronic hepatitis C: Familial aggregation of spontaneous and treatment-related viral clearance.

Authors:  Michael W Fried; Barbara L Kroner; Liliana R Preiss; Kirk Wilhelmsen; James J Goedert
Journal:  Gastroenterology       Date:  2006-09       Impact factor: 22.682

9.  Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q: schizophrenia linkage collaborative group III.

Authors:  D F Levinson; P Holmans; R E Straub; M J Owen; D B Wildenauer; P V Gejman; A E Pulver; C Laurent; K S Kendler; D Walsh; N Norton; N M Williams; S G Schwab; B Lerer; B J Mowry; A R Sanders; S E Antonarakis; J L Blouin; J F DeLeuze; J Mallet
Journal:  Am J Hum Genet       Date:  2000-08-02       Impact factor: 11.025

10.  High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus.

Authors:  T B Niewold; J Hua; T J A Lehman; J B Harley; M K Crow
Journal:  Genes Immun       Date:  2007-06-21       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.